Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Emisphere Reports Fourth Quarter and Full Year 2015 Financial Results
The Company to Host Conference Call Today at 8:30 AM ET
View HTML
Toggle Summary Emisphere Announces 2015 Earnings Conference Call
Conference Call/Webcast to be Held Tuesday, March 29, 2016, at 8:30 AM ET
View HTML
Toggle Summary Emisphere Reports Third Quarter 2015 Financial Results
Management to Host Conference Call Today at 8:30 AM ET
View HTML
Toggle Summary Emisphere Announces Third Quarter 2015 Financial Results Conference Call
Conference Call/Webcast to be Held Monday, November 16, 2015, at 8:30 AM ET
View HTML
Toggle Summary Emisphere to Present at SeeThruEquity MicroCap Investor Forum
ROSELAND, N.J. , Nov. 05, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino , will present at the SeeThruEquity MicroCap Investor Forum at 9:30 AM ET on Thursday, November 12, 2015 .
View HTML
Toggle Summary Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement
Emisphere to Receive $14 Million Upfront for New License and Amendment, Eligible for More Than $207 Million in Milestone Payments, Plus Royalties on Product Sales
View HTML
Toggle Summary Emisphere to Present at Rodman and Renshaw 17th Annual Global Investment Conference
ROSELAND, N.J. , Sept. 2, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino , will present at the Rodman and Renshaw 17 th Annual Global Investment Conference at 9:35 AM ET on Wednesday , September 9, 2015 .
View HTML
Toggle Summary Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1
Represents a Significant Validation of the Eligen Technology Platform
View HTML
Toggle Summary Emisphere Reports Second Quarter 2015 Financial Results
Management to Host Conference Call Today at 8:30 AM ET
View HTML
Toggle Summary Emisphere Announces Second Quarter 2015 Financial Results Conference Call
Conference Call/Webcast to be Held Wednesday, August 12, 2015, at 8:30 AM ET
View HTML
Toggle Summary Emisphere Reports First Quarter 2015 Financial Results
Management to Host Conference Call Today at 8:30 AM ET
View HTML
Toggle Summary Emisphere Announces First Quarter 2015 Financial Results Conference Call
Conference Call/Webcast to be Held Friday, May 15, 2015, at 8:30 AM ET
View HTML
Toggle Summary Emisphere Reports Fourth Quarter and Full Year 2014 Financial Results
Recent Launch of Eligen B12™ Marks Company's Expansion into Commercializing Practical Innovation Management to Host Conference Call Today at 8:30 AM ET ROSELAND, N.J. , March 31, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the fourth
View HTML
Toggle Summary Emisphere Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call
Conference Call/Webcast to be Held Tuesday, March 31, 2015, at 8:30 AM ET
View HTML
Toggle Summary Emisphere Launches Eligen B12™, the First Oral Prescription Tablet Proven to Normalize B12 Levels Without the Need for an Injection
- Oral tablet offers prescription strength B12 option for the estimated 48 million Americans with a B12 deficiency- Eligen® Technology being studied across multiple disease states, including diabetes- Eligen B12 marks Emisphere's expansion into commercializing practical innovations
View HTML

FOLLOW US